Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 236 articles: HTML format

Single Articles

July 2021
1. GOGLIN SE, Margaretten ME
   Malar Rash.
   N Engl J Med. 2021;385:164.
   PubMed    
   
   
   June 2021
2. O'CONNELL KA, LaChance AH
   Dermatomyositis.
   N Engl J Med. 2021;384:2437.
   PubMed    
   
   
   
3. SEEKER P, Osswald S
   Tongue Discoloration.
   N Engl J Med. 2021;384:e102.
   PubMed    
   
   
   
4. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
   Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
   N Engl J Med. 2021;384:2295-2305.
   PubMed     Abstract available
   
   
   May 2021
5. JAYNE DRW, Merkel PA, Bekker P
   Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
   N Engl J Med. 2021;384:e81.
   PubMed    
   
   
   
6. MATSUO Y, Miyabe Y
   Avacopan for the Treatment of ANCA-Associated Vasculitis.
   N Engl J Med. 2021;384:e81.
   PubMed    
   
   
   
7. CHANDWAR K
   Avacopan for the Treatment of ANCA-Associated Vasculitis.
   N Engl J Med. 2021;384:e81.
   PubMed    
   
   
   
8. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
   A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
   N Engl J Med. 2021;384:2014-2027.
   PubMed     Abstract available
   
   
   
9. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
   Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
   N Engl J Med. 2021;384:1849-1857.
   PubMed    
   
   
   
10. FRALICK M, Sarma S
    Thyrotoxic Periodic Paralysis.
    N Engl J Med. 2021;384:e71.
    PubMed    
    
    
    
11. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    PubMed    
    
    
    April 2021
12. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
    Case 13-2021: A Newborn Girl with a Neck Mass.
    N Engl J Med. 2021;384:1647-1655.
    PubMed    
    
    
    
13. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    PubMed     Abstract available
    
    
    
14. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    PubMed     Abstract available
    
    
    
15. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    PubMed     Abstract available
    
    
    
16. ZONOZI R, Niles JL
    Sunken Nose.
    N Engl J Med. 2021;384:e52.
    PubMed    
    
    
    March 2021
17. BUTLER PC
    Supplying Insulin while Evading Immunity.
    N Engl J Med. 2021;384:967-969.
    PubMed    
    
    
    February 2021
18. WARRINGTON KJ
    Avacopan - Time to Replace Glucocorticoids?
    N Engl J Med. 2021;384:664-665.
    PubMed    
    
    
    
19. JAYNE DRW, Merkel PA, Schall TJ, Bekker P, et al
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:599-609.
    PubMed     Abstract available
    
    
    
20. GOVERMAN JM
    Regulatory T Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:578-580.
    PubMed    
    
    
    
21. WU C, Dai R
    Central Retinal Artery and Vein Occlusion.
    N Engl J Med. 2021;384:e9.
    PubMed    
    
    
    January 2021
22. ZAMVIL SS, Hauser SL
    Antigen Presentation by B Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:378-381.
    PubMed    
    
    
    
23. FURIE R, Rovin BH, Roth DA
    Belimumab in Lupus Nephritis. Reply.
    N Engl J Med. 2021;384:188.
    PubMed    
    
    
    
24. SCHONERMARCK U, Kemmner S, Fischereder M
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187-188.
    PubMed    
    
    
    
25. ROJAS-RIVERA J, Ortiz A, Carriazo S
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187.
    PubMed    
    
    
    
26. ANDERSON MS, Chaimowitz NS, Forbes LR
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply.
    N Engl J Med. 2021;384:93-94.
    PubMed    
    
    
    
27. JOHNSON MB, Hattersley AT, Patel KA
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition.
    N Engl J Med. 2021;384:93.
    PubMed    
    
    
    December 2020
28. LEVY-LAHAD E, King MC
    Hiding in Plain Sight - Somatic Mutation in Human Disease.
    N Engl J Med. 2020;383:2680-2682.
    PubMed    
    
    
    
29. BECK DB, Ferrada MA, Sikora KA, Ombrello AK, et al
    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2020;383:2628-2638.
    PubMed     Abstract available
    
    
    
30. BRETON MD, Beck RW, Wadwa RP
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2020;383:2484.
    PubMed    
    
    
    
31. FERNANDES N
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:2484.
    PubMed    
    
    
    
32. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    PubMed    
    
    
    November 2020
33. ADANG L, Goldbach-Mansky R, Vanderver A
    JAK Inhibition in the Aicardi-Goutieres Syndrome. Reply.
    N Engl J Med. 2020;383:2191-2193.
    PubMed    
    
    
    
34. NEVEN B, Al Adba B, Hully M, Desguerre I, et al
    JAK Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:2190-2191.
    PubMed    
    
    
    
35. ACCILI D
    Whither Type 1 Diabetes?
    N Engl J Med. 2020;383:2078-2079.
    PubMed    
    
    
    
36. QUATTRIN T, Haller MJ, Steck AK, Felner EI, et al
    Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    N Engl J Med. 2020;383:2007-2017.
    PubMed     Abstract available
    
    
    
37. CAPLAN DN, Rapalino O, Karaa A, Rosovsky RP, et al
    Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation.
    N Engl J Med. 2020;383:1974-1983.
    PubMed    
    
    
    
38. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    PubMed    
    
    
    October 2020
39. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    
    
    
    
40. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    PubMed    
    
    
    
41. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    PubMed    
    
    
    
42. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    PubMed    
    
    
    
43. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    PubMed    
    
    
    
44. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    PubMed    
    
    
    
45. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    PubMed    
    
    
    
46. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    PubMed    
    
    
    
47. GO JR, Abu Saleh OM
    Vancomycin-Induced Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;383:1577.
    PubMed    
    
    
    
48. MIZUSHIMA N, Levine B
    Autophagy in Human Diseases.
    N Engl J Med. 2020;383:1564-1576.
    PubMed    
    
    
    
49. OH JY
    Autoimmune Keratitis after Atezolizumab Treatment.
    N Engl J Med. 2020;383:1468.
    PubMed    
    
    
    
50. CHAIMOWITZ NS, Ebenezer SJ, Hanson IC, Anderson M, et al
    STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.
    N Engl J Med. 2020;383:1494-1496.
    PubMed    
    
    
    September 2020
51. WANG G, Li H, Yang X, Guo T, et al
    Guillain-Barre Syndrome Associated with JEV Infection.
    N Engl J Med. 2020;383:1188-1190.
    PubMed    
    
    
    
52. WARD M, Tektonidou MG
    Belimumab as Add-on Therapy in Lupus Nephritis.
    N Engl J Med. 2020;383:1184-1185.
    PubMed    
    
    
    
53. OSTENDORF L, Burns M, Durek P, Heinz GA, et al
    Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2020;383:1149-1155.
    PubMed     Abstract available
    
    
    
54. FURIE R, Rovin BH, Houssiau F, Malvar A, et al
    Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    N Engl J Med. 2020;383:1117-1128.
    PubMed     Abstract available
    
    
    
55. BLUESTONE JA, Anderson M
    Tolerance in the Age of Immunotherapy.
    N Engl J Med. 2020;383:1156-1166.
    PubMed    
    
    
    
56. TRAPNELL BC, Inoue Y, Bonella F, Morgan C, et al
    Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2020 Sep 7. doi: 10.1056/NEJMoa1913590.
    PubMed     Abstract available
    
    
    
57. VANDERVER A, Adang L, Gavazzi F, McDonald K, et al
    Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:986-989.
    PubMed    
    
    
    August 2020
58. BRETON MD, Kanapka LG, Beck RW, Ekhlaspour L, et al
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:836-845.
    PubMed     Abstract available
    
    
    
59. MUELLER AA, Vaidya A, Tarter LL, Klein JP, et al
    Caught in a Flare.
    N Engl J Med. 2020;383:e48.
    PubMed    
    
    
    
60. HAUSER SL, Bar-Or A, Cohen JA, Comi G, et al
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    N Engl J Med. 2020;383:546-557.
    PubMed     Abstract available
    
    
    July 2020
61. WU K
    Uncertain Trust.
    N Engl J Med. 2020;383:204-205.
    PubMed    
    
    
    
62. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    PubMed    
    
    
    
63. GAY E
    Blame.
    N Engl J Med. 2020;383:9.
    PubMed    
    
    
    June 2020
64. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    PubMed    
    
    
    
65. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    PubMed     Abstract available
    
    
    
66. DORIA A, Galecki AT, Spino C, Pop-Busui R, et al
    Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    N Engl J Med. 2020;382:2493-2503.
    PubMed     Abstract available
    
    
    
67. VICO-ALONSO C, Palencia-Perez S
    Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;382:2248.
    PubMed    
    
    
    May 2020
68. WALSH M, Merkel PA, Jayne DRW
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2020;382:2169.
    PubMed    
    
    
    
69. ESPOSITO P, Cipriani L, Viazzi F
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168-2169.
    PubMed    
    
    
    
70. SEXTON DJ
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168.
    PubMed    
    
    
    
71. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    PubMed    
    
    
    
72. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    PubMed    
    
    
    
73. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    PubMed    
    
    
    
74. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    PubMed    
    
    
    April 2020
75. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    PubMed    
    
    
    
76. MORAND EF, Furie RA
    Anifrolumab in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2020;382:1666.
    PubMed    
    
    
    
77. PUTMAN M
    Anifrolumab in Systemic Lupus Erythematosus.
    N Engl J Med. 2020;382:1665-1666.
    PubMed    
    
    
    
78. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    PubMed    
    
    
    
79. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    PubMed    
    
    
    
80. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    PubMed    
    
    
    March 2020
81. COOPER N, Ghanima W
    Immune Thrombocytopenia. Reply.
    N Engl J Med. 2020;382:1077-1078.
    PubMed    
    
    
    
82. NOHRIA V, Macie AC
    Immune Thrombocytopenia.
    N Engl J Med. 2020;382:1077.
    PubMed    
    
    
    
83. SOCAL MP, Greene JA
    Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.
    N Engl J Med. 2020;382:981-983.
    PubMed    
    
    
    
84. BELLO F, Fagni F
    Nasal Deformity in Granulomatosis with Polyangiitis.
    N Engl J Med. 2020;382:951.
    PubMed    
    
    
    February 2020
85. DEREBAIL VK, Falk RJ
    ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.
    N Engl J Med. 2020;382:671-673.
    PubMed    
    
    
    
86. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    PubMed     Abstract available
    
    
    
87. KOVATCHEV BP, Brown SA, Beck RW
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Reply.
    N Engl J Med. 2020;382:578.
    PubMed    
    
    
    
88. ZUNIGA-HERNANDEZ JA, Medrano-De Avila C, Rodriguez-Gutierrez R
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577-578.
    PubMed    
    
    
    
89. TAKITA M
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577.
    PubMed    
    
    
    January 2020
90. DOUGLAS RS, Kahaly GJ, Patel A, Sile S, et al
    Teprotumumab for the Treatment of Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:341-352.
    PubMed     Abstract available
    
    
    
91. SALMON JE, Niewold TB
    A Successful Trial for Lupus - How Good Is Good Enough?
    N Engl J Med. 2020;382:287-288.
    PubMed    
    
    
    
92. AZAR MM, Muse VV, Villalba JA, Turbett SE, et al
    Case 2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
    N Engl J Med. 2020;382:276-285.
    PubMed    
    
    
    
93. FASANO A, Leonard MM, Mitchell DM, Eng G, et al
    Case 1-2020: An 11-Year-Old Boy with Vomiting and Weight Loss.
    N Engl J Med. 2020;382:180-189.
    PubMed    
    
    
    December 2019
94. MORAND EF, Furie R, Tanaka Y, Bruce IN, et al
    Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2019 Dec 18. doi: 10.1056/NEJMoa1912196.
    PubMed     Abstract available
    
    
    November 2019
95. YAMAMURA T, Kleiter I, Fujihara K, Palace J, et al
    Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:2114-2124.
    PubMed     Abstract available
    
    
    
96. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia. Reply.
    N Engl J Med. 2019;381:1881-1882.
    PubMed    
    
    
    
97. SHVIDEL L, Stanevsky A, Sigler E
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:1881.
    PubMed    
    
    
    
98. HEROLD KC, Bundy BN, Krischer JP
    Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply.
    N Engl J Med. 2019;381:1880-1881.
    PubMed    
    
    
    
99. KORSGREN O, Skog O, Ludvigsson J
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879-1880.
    PubMed    
    
    
    
100. COURI CE, Malmegrim KCR, Oliveira MC
     Teplizumab in Relatives at Risk for Type 1 Diabetes.
     N Engl J Med. 2019;381:1879.
     PubMed    
     
     
     
101. ILANY J
     Teplizumab in Relatives at Risk for Type 1 Diabetes.
     N Engl J Med. 2019;381:1879.
     PubMed    
     
     
     
102. SMITH C, Dhaliwal G, Saint S, Farkash EA, et al
     Double Trouble.
     N Engl J Med. 2019;381:1854-1860.
     PubMed    
     
     
     October 2019
103. BRUTTOMESSO D
     Toward Automated Insulin Delivery.
     N Engl J Med. 2019;381:1774-1775.
     PubMed    
     
     
     
104. FERVENZA FC, Cattran DC
     Rituximab or Cyclosporine for Membranous Nephropathy. Reply.
     N Engl J Med. 2019;381:1689-1690.
     PubMed    
     
     
     
105. PONTICELLI C, Moroni G
     Rituximab or Cyclosporine for Membranous Nephropathy.
     N Engl J Med. 2019;381:1688-1689.
     PubMed    
     
     
     
106. WALDMAN M, Austin HA 3rd, Balow JE
     Rituximab or Cyclosporine for Membranous Nephropathy.
     N Engl J Med. 2019;381:1688.
     PubMed    
     
     
     
107. VALOTI E, Noris M, Remuzzi G
     More about Factor H Autoantibodies in Membranous Nephropathy.
     N Engl J Med. 2019;381:1590-1592.
     PubMed    
     
     
     
108. LI J, Zhou Z
     Calcinosis in Juvenile Dermatomyositis.
     N Engl J Med. 2019;381:e31.
     PubMed    
     
     
     
109. CHWALISZ BK, Buchbinder BR, Schmahmann JD, Samore WR, et al
     Case 32-2019: A 70-Year-Old Woman with Rapidly Progressive Ataxia.
     N Engl J Med. 2019;381:1569-1578.
     PubMed    
     
     
     
110. BROWN SA, Kovatchev BP, Raghinaru D, Lum JW, et al
     Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
     N Engl J Med. 2019 Oct 16. doi: 10.1056/NEJMoa1907863.
     PubMed     Abstract available
     
     
     
111. TUNKEL AR, Baron EL, Buch KA, Marty FM, et al
     Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence.
     N Engl J Med. 2019;381:1459-1470.
     PubMed    
     
     
     
112. MUSSO D, Ko AI, Baud D
     Zika Virus Infection - After the Pandemic.
     N Engl J Med. 2019;381:1444-1457.
     PubMed    
     
     
     September 2019
113. SHARMA K, Patel A
     Livedo Reticularis in Cold Agglutinin Disease.
     N Engl J Med. 2019;381:e27.
     PubMed    
     
     
     
114. COOPER N, Ghanima W
     Immune Thrombocytopenia.
     N Engl J Med. 2019;381:945-955.
     PubMed    
     
     
     
115. TAZAWA R, Ueda T, Abe M, Tatsumi K, et al
     Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
     N Engl J Med. 2019;381:923-932.
     PubMed     Abstract available
     
     
     August 2019
116. BRODSKY RA
     Warm Autoimmune Hemolytic Anemia.
     N Engl J Med. 2019;381:647-654.
     PubMed    
     
     
     
117. PITTOCK SJ, Berthele A, Fujihara K, Kim HJ, et al
     Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
     N Engl J Med. 2019;381:614-625.
     PubMed     Abstract available
     
     
     
118. CHIAPPA V, Anderson MA, Barrett CD, Stathatos N, et al
     Case 24-2019: A 39-Year-Old Woman with Palpitations, Abdominal Pain, and Vomiting.
     N Engl J Med. 2019;381:567-577.
     PubMed    
     
     
     
119. CHARROW A, Vleugels RA
     Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
     N Engl J Med. 2019;381:465.
     PubMed    
     
     
     July 2019
120. CHEN Z, Wang X, Ye S
     Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
     N Engl J Med. 2019;381:291-293.
     PubMed    
     
     
     
121. FREEMAN MW, Singh AK, Guidon AC, Arvikar SL, et al
     Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
     N Engl J Med. 2019;381:275-283.
     PubMed    
     
     
     
122. DEUTSCHER S
     Phage Display to Detect and Identify Autoantibodies in Disease.
     N Engl J Med. 2019;381:89-91.
     PubMed    
     
     
     
123. RUGGENENTI P, Remuzzi G
     A First Step toward a New Approach to Treating Membranous Nephropathy.
     N Engl J Med. 2019;381:86-88.
     PubMed    
     
     
     
124. FERVENZA FC, Appel GB, Barbour SJ, Rovin BH, et al
     Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
     N Engl J Med. 2019;381:36-46.
     PubMed     Abstract available
     
     
     
125. LEE I, Walker JB, Nozaki K, Willett LL, et al
     Weak and Winded.
     N Engl J Med. 2019;381:76-82.
     PubMed    
     
     
     June 2019
126. ROSEN CJ, Ingelfinger JR
     Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.
     N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMe1907458.
     PubMed    
     
     
     
127. HEROLD KC, Bundy BN, Long SA, Bluestone JA, et al
     An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
     N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
     PubMed     Abstract available
     
     
     
128. BRAUN DA, Henderson GV, Sax PE, Miller AL, et al
     A Disturbing Decline.
     N Engl J Med. 2019;380:2257-2262.
     PubMed    
     
     
     May 2019
129. ARVIKAR SL, Schoenfeld SR, Fox AS, Tanguturi VK, et al
     Case 17-2019: A 44-Year-Old Man with Joint Pain, Weight Loss, and Chest Pain.
     N Engl J Med. 2019;380:2157-2167.
     PubMed    
     
     
     
130. BRAUN DA, Simchowitz B, Henderson GV, Sax PE, et al
     A Disturbing Decline.
     N Engl J Med. 2019;380:e42.
     PubMed    
     
     
     
131. DE LA FUENTE J, Bird J
     Coronary Arteritis in IgG4-Related Disease.
     N Engl J Med. 2019;380:2156.
     PubMed    
     
     
     
132. IEZZONI LI
     Dangers of Diagnostic Overshadowing.
     N Engl J Med. 2019;380:2092-2093.
     PubMed    
     
     
     
133. MONTALBAN X, Arnold DL, Weber MS, Staikov I, et al
     Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
     N Engl J Med. 2019 May 10. doi: 10.1056/NEJMoa1901981.
     PubMed     Abstract available
     
     
     April 2019
134. ROGERS KK
     Diabetes and Disclosure.
     N Engl J Med. 2019;380:1495-1497.
     PubMed    
     
     
     March 2019
135. HENDERSON CM, Fink SL, Bassyouni H, Argiropoulos B, et al
     Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
     N Engl J Med. 2019;380:1150-1157.
     PubMed     Abstract available
     
     
     December 2018
136. SEIKRIT C, Ronco P, Debiec H
     Factor H Autoantibodies and Membranous Nephropathy.
     N Engl J Med. 2018;379:2479-2481.
     PubMed    
     
     
     
137. LEFEBVRE DR, Reinshagen KL, Yoon MK, Stone JH, et al
     Case 39-2018: An 18-Year-Old Man with Diplopia and Proptosis of the Left Eye.
     N Engl J Med. 2018;379:2452-2461.
     PubMed    
     
     
     
138. RICE GI, Meyzer C, Bouazza N, Hully M, et al
     Reverse-Transcriptase Inhibitors in the Aicardi-Goutieres Syndrome
     N Engl J Med. 2018;379:2275-7.
     PubMed    
     
     
     November 2018
139. MARCHAND L
     Closed-Loop Insulin for Glycemic Control in Noncritical Care.
     N Engl J Med. 2018;379:1970.
     PubMed    
     
     
     
140. LAL A, Katta SR, Trivedi N
     Closed-Loop Insulin for Glycemic Control in Noncritical Care.
     N Engl J Med. 2018;379:1970.
     PubMed    
     
     
     
141. BALLY L, Thabit H, Hovorka R
     Closed-Loop Insulin for Glycemic Control in Noncritical Care.
     N Engl J Med. 2018;379:1970-1971.
     PubMed    
     
     
     
142. DOWNING NS, McMullan CJ, Rennke HG, Levy BD, et al
     Complements from the Lung.
     N Engl J Med. 2018;379:1767-1773.
     PubMed    
     
     
     September 2018
143. LACKNER KJ, MullerCalleja N
     Diagnosis and Management of the Antiphospholipid Syndrome.
     N Engl J Med. 2018;379:1290.
     PubMed    
     
     
     
144. RIERA-MESTRE A, Vidaller A
     Diagnosis and Management of the Antiphospholipid Syndrome.
     N Engl J Med. 2018;379:1289-90.
     PubMed    
     
     
     
145. CIAVARELLA A, Martinelli I
     Diagnosis and Management of the Antiphospholipid Syndrome.
     N Engl J Med. 2018;379:1289.
     PubMed    
     
     
     
146. 
     Diagnosis and Management of the Antiphospholipid Syndrome.
     N Engl J Med. 2018;379:1289-1290.
     PubMed    
     
     
     
147. MANDAL J, Margaretten M
     Tuberculosis of the Finger.
     N Engl J Med. 2018;379:1161.
     PubMed    
     
     
     
148. ANTEL J
     Therapy in Multiple Sclerosis - Coming of Age.
     N Engl J Med. 2018;379:1085-1086.
     PubMed    
     
     
     
149. CHITNIS T, Arnold DL, Banwell B, Bruck W, et al
     Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
     N Engl J Med. 2018;379:1017-1027.
     PubMed     Abstract available
     
     
     August 2018
150. FOX RJ, Coffey CS, Conwit R, Cudkowicz ME, et al
     Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
     N Engl J Med. 2018;379:846-855.
     PubMed     Abstract available
     
     
     
151. GORMAN MP, Gombolay GY, Mehan WA Jr, Thibert RL, et al
     Case 27-2018: A 3-Year-Old Boy with Seizures.
     N Engl J Med. 2018;379:870-878.
     PubMed    
     
     
     
152. FALK RJ, Husseini JS, Fenves AZ, Rosales IA, et al
     Case 24-2018: A 71-Year-Old Man with Acute Renal Failure and Hematuria.
     N Engl J Med. 2018;379:568-578.
     PubMed    
     
     
     June 2018
153. SEPE V, Velluzzi F, Songini M
     Autoimmune Polyendocrine Syndromes.
     N Engl J Med. 2018;378:2543.
     PubMed    
     
     
     
154. YANAI H
     Autoimmune Polyendocrine Syndromes.
     N Engl J Med. 2018;378:2542-3.
     PubMed    
     
     
     
155. TRUFFAUT L, Lefebvre P
     Tongue Necrosis in Giant-Cell Arteritis.
     N Engl J Med. 2018;378:2517.
     PubMed    
     
     
     
156. 
     Autoimmune Polyendocrine Syndromes.
     N Engl J Med. 2018;378:2542-2544.
     PubMed    
     
     
     
157. ROSENBAUM JT, Silverman GJ
     The Microbiome and Systemic Lupus Erythematosus.
     N Engl J Med. 2018;378:2236-2237.
     PubMed    
     
     
     May 2018
158. MORRIS CA, Patel MJ, Fenves AZ, Masia R, et al
     Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain.
     N Engl J Med. 2018;378:2124-2132.
     PubMed    
     
     
     
159. GARCIA D, Erkan D
     Diagnosis and Management of the Antiphospholipid Syndrome.
     N Engl J Med. 2018;378:2010-2021.
     PubMed    
     
     
     March 2018
160. HUSEBYE ES, Anderson MS, Kampe O
     Autoimmune Polyendocrine Syndromes.
     N Engl J Med. 2018;378:1132-1141.
     PubMed    
     
     
     
161. KHOO TK, Olson KM
     Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
     N Engl J Med. 2018;378:967.
     PubMed    
     
     
     
162. DOUMAS M, Imprialos KP, Stavropoulos K
     Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
     N Engl J Med. 2018;378:967.
     PubMed    
     
     
     
163. CONTE C, Secchi A, Napoli N
     Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
     N Engl J Med. 2018;378:966.
     PubMed    
     
     
     
164. GOGTAY NJ, Bose D, Thatte UM
     Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
     N Engl J Med. 2018;378:966.
     PubMed    
     
     
     
165. 
     Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
     N Engl J Med. 2018;378:966-968.
     PubMed    
     
     
     
166. DALMAU J, Graus F
     Antibody-Mediated Encephalitis.
     N Engl J Med. 2018;378:840-851.
     PubMed    
     
     
     
167. CASEY JD, Englert JA, Katz JT, Miller AL, et al
     An Unexpected Expectoration.
     N Engl J Med. 2018;378:853-858.
     PubMed    
     
     
     February 2018
168. KNUESEL SJ, Guseh JS 2nd, Karp Leaf R, Ciaranello AL, et al
     Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia.
     N Engl J Med. 2018;378:753-760.
     PubMed    
     
     
     
169. FLYNN JT
     ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
     N Engl J Med. 2018;378:580.
     PubMed    
     
     
     
170. MEI ZB, Xiao Y
     ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
     N Engl J Med. 2018;378:579.
     PubMed    
     
     
     
171. JONNALAGADDA VG, Metety VK
     ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
     N Engl J Med. 2018;378:579.
     PubMed    
     
     
     
172. 
     ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
     N Engl J Med. 2018;378:579-581.
     PubMed    
     
     
     January 2018
173. CESTARI DM, Cunnane ME, Rizzo JF 3rd, Stone JH, et al
     Case 2-2018. A 41-Year-Old Woman with Vision Disturbances and Headache.
     N Engl J Med. 2018;378:282-289.
     PubMed    
     
     
     
174. REICH DS, Lucchinetti CF, Calabresi PA
     Multiple Sclerosis.
     N Engl J Med. 2018;378:169-180.
     PubMed    
     
     
     December 2017
175. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:2267-2272.
     PubMed    
     
     
     November 2017
176. GHIASI M
     Strawberry Gingivitis in Granulomatosis with Polyangiitis.
     N Engl J Med. 2017;377:2073.
     PubMed    
     
     
     
177. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:e29.
     PubMed    
     
     
     
178. MARCOVECCHIO ML, Chiesa ST, Bond S, Daneman D, et al
     ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
     N Engl J Med. 2017;377:1733-1745.
     PubMed     Abstract available
     
     
     October 2017
179. PALAMARA K, Nagarur A, Fintelmann FJ, Kohler MJ, et al
     Case 32-2017. A 64-Year-Old Man with Dyspnea, Wheezing, Headache, Cough, and Night Sweats.
     N Engl J Med. 2017;377:1569-1578.
     PubMed    
     
     
     
180. AKIYAMA M
     Trial of Tocilizumab in Giant-Cell Arteritis.
     N Engl J Med. 2017;377:1493-4.
     PubMed    
     
     
     
181. GONZALES-GAY MA, Loricera J, Blanco R
     Trial of Tocilizumab in Giant-Cell Arteritis.
     N Engl J Med. 2017;377:1493.
     PubMed    
     
     
     
182. STONE JH, Klearman M, Collinson N
     Trial of Tocilizumab in Giant-Cell Arteritis.
     N Engl J Med. 2017;377:1494-1495.
     PubMed    
     
     
     
183. 
     Trial of Tocilizumab in Giant-Cell Arteritis.
     N Engl J Med. 2017;377:1493.
     PubMed    
     
     
     
184. ROSENBAUM JT
     Celiac Disease and Autoimmunity - The Missing Ingredient.
     N Engl J Med. 2017;377:1489-1490.
     PubMed    
     
     
     September 2017
185. BHATTACHARYYA RP, Flores EJ, Azar MM
     Case 30-2017. A 65-Year-Old Woman with Altered Mental Status, Bacteremia, and Acute Liver Failure.
     N Engl J Med. 2017;377:1274-1282.
     PubMed    
     
     
     
186. NATHAN DM
     Adjunctive Treatments for Type 1 Diabetes.
     N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMe1711296.
     PubMed    
     
     
     
187. GARG SK, Henry RR, Banks P, Buse JB, et al
     Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
     N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMoa1708337.
     PubMed     Abstract available
     
     
     
188. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
     Connecting the Dots.
     N Engl J Med. 2017;377:978-984.
     PubMed    
     
     
     August 2017
189. PENG S, Sun X, Sun M
     Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
     N Engl J Med. 2017;377:789.
     PubMed    
     
     
     
190. 
     Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
     N Engl J Med. 2017;377:789-790.
     PubMed    
     
     
     
191. METZ LM, Eliasziw M
     Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
     N Engl J Med. 2017;377:789.
     PubMed    
     
     
     
192. 
     Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
     N Engl J Med. 2017;377:788-789.
     PubMed    
     
     
     
193. DIVAKARAN S, Dellaripa P, Kobzik L, Levy B, et al
     All That Wheezes....
     N Engl J Med. 2017;377:477-484.
     PubMed    
     
     
     July 2017
194. HALLER M, Atkinson M, Schatz D
     More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
     N Engl J Med. 2017;377:403.
     PubMed    
     
     
     
195. HELLMANN DB
     Giant-Cell Arteritis - More Ecstasy, Less Agony.
     N Engl J Med. 2017;377:385-386.
     PubMed    
     
     
     
196. 
     More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
     N Engl J Med. 2017;377:403-5.
     PubMed    
     
     
     
197. STONE JH, Tuckwell K, Dimonaco S, Klearman M, et al
     Trial of Tocilizumab in Giant-Cell Arteritis.
     N Engl J Med. 2017;377:317-328.
     PubMed     Abstract available
     
     
     
198. 
     Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
     N Engl J Med. 2017;377:405.
     PubMed    
     
     
     
199. DIVAKARAN S, Vaidya A, Kobzik L, Dellaripa P, et al
     All That Wheezes...
     N Engl J Med. 2017;377:e6.
     PubMed    
     
     
     
200. 
     Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
     N Engl J Med. 2017;377:301.
     PubMed    
     
     
     
201. MARTINEZ-CERON E, Garcia-Rio F
     Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
     N Engl J Med. 2017;377:300.
     PubMed    
     
     
     
202. 
     Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
     N Engl J Med. 2017;377:301.
     PubMed    
     
     
     
203. NATHAN DM, Bebu I, Lachin JM
     Frequency of Evidence-Based Screening for Diabetic Retinopathy.
     N Engl J Med. 2017;377:195.
     PubMed    
     
     
     
204. 
     Frequency of Evidence-Based Screening for Diabetic Retinopathy.
     N Engl J Med. 2017;377:194-195.
     PubMed    
     
     
     
205. KUMAR S, Sharma VK
     Unmasking Ptosis in Both Eyes.
     N Engl J Med. 2017;377:e1.
     PubMed    
     
     
     June 2017
206. XIA Z, Friedlander RM
     Minocycline in Multiple Sclerosis - Compelling Results but Too Early to Tell.
     N Engl J Med. 2017;376:2191-2193.
     PubMed    
     
     
     
207. METZ LM, Li DKB, Traboulsee AL, Duquette P, et al
     Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
     N Engl J Med. 2017;376:2122-2133.
     PubMed     Abstract available
     
     
     May 2017
208. ESFAHANI K, Miller WH Jr
     Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
     N Engl J Med. 2017;376:1989-91.
     PubMed    
     
     
     
209. WECHSLER ME, Akuthota P, Jayne D, Khoury P, et al
     Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
     N Engl J Med. 2017;376:1921-1932.
     PubMed     Abstract available
     
     
     
210. DJUKANOVIC R, O'Byrne PM
     Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.
     N Engl J Med. 2017;376:1985-1986.
     PubMed    
     
     
     
211. BAIDAL DA, Ricordi C, Berman DM, Alvarez A, et al
     Bioengineering of an Intraabdominal Endocrine Pancreas.
     N Engl J Med. 2017;376:1887-1889.
     PubMed    
     
     
     
212. 
     Randomized Trial of Thymectomy in Myasthenia Gravis.
     N Engl J Med. 2017 May 4. doi: 10.1056/NEJMx170003.
     PubMed    
     
     
     
213. SMITH TJ, Kahaly GJ, Ezra DG, Fleming JC, et al
     Teprotumumab for Thyroid-Associated Ophthalmopathy.
     N Engl J Med. 2017;376:1748-1761.
     PubMed     Abstract available
     
     
     
214. RAMSEY BW, Nepom GT, Lonial S
     Academic, Foundation, and Industry Collaboration in Finding New Therapies.
     N Engl J Med. 2017;376:1762-1769.
     PubMed    
     
     
     April 2017
215. DEISENHAMMER F, Auer M, Hegen H
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1693-4.
     PubMed    
     
     
     
216. MILDINER S, Malnick S
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1692-3.
     PubMed    
     
     
     
217. SHARP MK
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1692.
     PubMed    
     
     
     
218. STERI M, Orru V, Idda ML, Pitzalis M, et al
     Overexpression of the Cytokine BAFF and Autoimmunity Risk.
     N Engl J Med. 2017;376:1615-1626.
     PubMed     Abstract available
     
     
     
219. KORN T, Oukka M
     A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
     N Engl J Med. 2017;376:1680-1681.
     PubMed    
     
     
     
220. MONTALBAN X, Belachew S, Wolinsky JS
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1694.
     PubMed    
     
     
     
221. SCHOERGENHOFER C, Jilma B
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1693.
     PubMed    
     
     
     
222. HAUSER SL, Belachew Sh, Kappos L
     Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
     N Engl J Med. 2017;376:1694.
     PubMed    
     
     
     
223. RAMANAN AV, Dick AD, Jones AP, McKay A, et al
     Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
     N Engl J Med. 2017;376:1637-1646.
     PubMed     Abstract available
     
     
     
224. THORNE JE
     Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis.
     N Engl J Med. 2017;376:1682-1683.
     PubMed    
     
     
     
225. 
     Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
     N Engl J Med. 2017;376:1507-1516.
     PubMed     Abstract available
     
     
     
226. INGELFINGER JR, Jarcho JA
     Increase in the Incidence of Diabetes and Its Implications.
     N Engl J Med. 2017;376:1473-1474.
     PubMed    
     
     
     
227. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
     Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
     N Engl J Med. 2017;376:1419-1429.
     PubMed     Abstract available
     
     
     
228. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
     Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
     N Engl J Med. 2017;376:1407-1418.
     PubMed     Abstract available
     
     
     
229. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
     A Bare-Bones Approach.
     N Engl J Med. 2017;376:1371-1376.
     PubMed    
     
     
     
230. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
     Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
     N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
     PubMed     Abstract available
     
     
     March 2017
231. MIRANDA S, Reid DK, John ChS
     Myasthenia Gravis.
     N Engl J Med. 2017;376:e25.
     PubMed    
     
     
     
232. PRIOLA AM, Veltri A, Priola SM
     Myasthenia Gravis.
     N Engl J Med. 2017;376:e25.
     PubMed    
     
     
     
233. INDRARATNA P, Matar W
     Myasthenia Gravis.
     N Engl J Med. 2017;376:e25.
     PubMed    
     
     
     
234. GILHUS NE
     Myasthenia Gravis.
     N Engl J Med. 2017;376:e25.
     PubMed    
     
     
     
235. DE OLIVEIRA WK, Carmo EH, Henriques CM, Coelho G, et al
     Zika Virus Infection and Associated Neurologic Disorders in Brazil.
     N Engl J Med. 2017 Mar 29. doi: 10.1056/NEJMc1608612.
     PubMed    
     
     
     
236. NAGARUR A, Axelrod L, Dighe AS
     Case 9-2017. A 27-Year-Old Woman with Nausea, Vomiting, Confusion, and Hyponatremia.
     N Engl J Med. 2017;376:1159-1167.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: